Telomerase activation by genomic rearrangements in high-risk neuroblastomaMartin Peifer, Johannes H. Schulte, Andrea Krämer et al.|Nature|2015Cited by 608
The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma modelsKristian W. Pajtler, Johannes H. Schulte|Oncotarget|2016Cited by 44
Newborn Screening and Presymptomatic Treatment of Metachromatic LeukodystrophyLucia Laugwitz, Samuel Groeschel, Thomas P. Mechtler et al.|New England Journal of Medicine|2024Cited by 20